Key points are not available for this paper at this time.
Neonatal sepsis is considered as alarming medical emergency and becomes the common global reason of neonatal mortality. Non-specific symptoms and limitations of conventional diagnostic methods for neonatal sepsis mandate fast and reliable method to diagnose disease for point of care application. Recently, disease specific biomarkers have gained interest for rapid diagnosis that led to the development of electrochemical biosensor with enhanced specificity, sensitivity, cost-effectiveness and user-friendliness. Other than conventional biomarker C-reactive protein to diagnose neonatal sepsis, several potential biomarkers including Procalcitonin (PCT), Serum amyloid A (SAA) and other candidates are extensively investigated. The present review provides insights on advancements and diagnostic abilities of protein and nucleotide based biomarkers with their incorporation in developing electrochemical biosensors by employing novel fabrication strategies. This review provides an overview of most promising biomarker and its capability for neonatal sepsis diagnosis to fulfil future demand to develop electrochemical biosensor for point-of-care applications.
Building similarity graph...
Analyzing shared references across papers
Loading...
Neha Gopal
Nidhi Chauhan
Utkarsh Jain
SHILAP Revista de lepidopterología
Artificial Cells Nanomedicine and Biotechnology
Erasmus MC
University of Delhi
Amity University
Building similarity graph...
Analyzing shared references across papers
Loading...
Gopal et al. (Fri,) studied this question.
www.synapsesocial.com/papers/69d99d572a25b240b7a3d196 — DOI: https://doi.org/10.1080/21691401.2023.2252016